Artesunate/Pyrimethamine/Sulfalene

青蒿琥酯/乙胺嘧啶/磺胺林

Report date: 2023/04/21 16:05:14

Base Information

Drug NameArtesunate/Pyrimethamine/Sulfalene

Drug Alias Name青蒿琥酯乙胺嘧啶磺胺林Pyrimethamine/Sulfalene/Artesunate磺胺林/青蒿琥酯/乙胺嘧啶Sulfalene/Artesunate/PyrimethamineArtesunic acid/Pyrimethamine/Sulfalene +[12]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDihydrofolate reductase inhibitorsDihydropteroate synthase inhibitorsSarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitors +[4]

TargetsDihydrofolate reductaseDihydropteroate synthaseSarcoplasmic/endoplasmic reticulum calcium ATPase 1 +[4]

Therapy Area/IndicationsMalaria

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Sulfalene Artesunate Pyrimethamine

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesDafra Pharma

China Registration ClassN/A

Develop Information

Active CompaniesDafra Pharma

Inactive CompaniesN/A

Active IndicationsMalaria

Inactive IndicationsN/A

Other Information

ATC CodeP01B